Psychometric profile of the Ages and Stages Questionnaires, Japanese translation.


Journal

Pediatrics international : official journal of the Japan Pediatric Society
ISSN: 1442-200X
Titre abrégé: Pediatr Int
Pays: Australia
ID NLM: 100886002

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 06 02 2018
revised: 21 05 2019
accepted: 02 07 2019
pubmed: 17 8 2019
medline: 6 5 2020
entrez: 17 8 2019
Statut: ppublish

Résumé

This study assessed the psychometric profile of 10 questionnaires (every 6 months, from 6 to 60 months) from the Japanese translation of the Ages and Stages Questionnaires, third edition (J-ASQ-3). Data from 439 children in a birth cohort were used to identify the J-ASQ-3 score distribution, establish cut-off scores, and calculate the instrument's internal consistency. Data were also collected from 491 outpatients to examine J-ASQ-3 test-retest reliability and concurrent validity, which was examined using the Kyoto Scale of Psychological Development (KSPD) and the Japanese version of the Denver Developmental Screening Test II (J-Denver II). Both the original and the alternative screening criteria of the ASQ-3 were used (failure in at least one and at least two domains, respectively). Cronbach's alpha for each J-ASQ-3 subscale on each questionnaire ranged from 0.45 to 0.89. Test-retest reliability was >0.75 for the subscales on almost all questionnaires. Concurrent validity was also adequate. In comparison with the screening results of the KSPD, the overall sensitivity and specificity were 96.0% and 48.8%, respectively, when the ASQ-3 original criterion was used, and 92.1% and 74.9%, respectively, when the alternative criterion was used. In comparison with the screening results of the J-Denver II, the overall sensitivity and specificity were 75.6% and 74.7%, respectively, when the ASQ-3 original criterion was used, and 56.3% and 93.0%, respectively, when the alternative criterion was used. This study quantified the psychometric profiles of the Japanese translations of 10 ASQ-3 questionnaires. We demonstrated the validity of the J-ASQ-3 and determined new cut-off scores. Further studies with larger samples from a greater range of locations are required to clarify the suitability of this tool for all Japanese children.

Sections du résumé

BACKGROUND BACKGROUND
This study assessed the psychometric profile of 10 questionnaires (every 6 months, from 6 to 60 months) from the Japanese translation of the Ages and Stages Questionnaires, third edition (J-ASQ-3).
METHODS METHODS
Data from 439 children in a birth cohort were used to identify the J-ASQ-3 score distribution, establish cut-off scores, and calculate the instrument's internal consistency. Data were also collected from 491 outpatients to examine J-ASQ-3 test-retest reliability and concurrent validity, which was examined using the Kyoto Scale of Psychological Development (KSPD) and the Japanese version of the Denver Developmental Screening Test II (J-Denver II). Both the original and the alternative screening criteria of the ASQ-3 were used (failure in at least one and at least two domains, respectively).
RESULTS RESULTS
Cronbach's alpha for each J-ASQ-3 subscale on each questionnaire ranged from 0.45 to 0.89. Test-retest reliability was >0.75 for the subscales on almost all questionnaires. Concurrent validity was also adequate. In comparison with the screening results of the KSPD, the overall sensitivity and specificity were 96.0% and 48.8%, respectively, when the ASQ-3 original criterion was used, and 92.1% and 74.9%, respectively, when the alternative criterion was used. In comparison with the screening results of the J-Denver II, the overall sensitivity and specificity were 75.6% and 74.7%, respectively, when the ASQ-3 original criterion was used, and 56.3% and 93.0%, respectively, when the alternative criterion was used.
CONCLUSIONS CONCLUSIONS
This study quantified the psychometric profiles of the Japanese translations of 10 ASQ-3 questionnaires. We demonstrated the validity of the J-ASQ-3 and determined new cut-off scores. Further studies with larger samples from a greater range of locations are required to clarify the suitability of this tool for all Japanese children.

Identifiants

pubmed: 31419360
doi: 10.1111/ped.13990
pmc: PMC6899956
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1086-1095

Subventions

Organisme : The Ministry of Environment

Informations de copyright

© 2019 The Authors. Pediatrics International published by John Wiley & Sons Australia, Ltd on behalf of Japan Pediatric Society.

Références

J Dev Behav Pediatr. 2011 Sep;32(7):499-511
pubmed: 21760526
Int J Med Educ. 2011 Jun 27;2:53-55
pubmed: 28029643
J Pediatr. 2013 Jul;163(1):36-42.e1
pubmed: 23312681
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Pediatrics. 1992 Jun;89(6 Pt 2):1221-5
pubmed: 1375732
Tohoku J Exp Med. 2017;242(1):1-8
pubmed: 28484113
Sci Rep. 2016 Aug 09;6:31396
pubmed: 27503177
Acta Paediatr. 2007 May;96(5):748-52
pubmed: 17462065
Pediatrics. 2013 May;131(5):e1468-74
pubmed: 23629619
J Epidemiol. 2018 Feb 5;28(2):99-104
pubmed: 29093304
BMC Public Health. 2014 Jan 10;14:25
pubmed: 24410977
Early Hum Dev. 2015 Sep;91(9):527-33
pubmed: 26162639
PLoS One. 2011;6(5):e20004
pubmed: 21637833

Auteurs

Hidetoshi Mezawa (H)

Developmental Evaluation Center, National Center for Child Health and Development, Tokyo, Japan.
Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Sayaka Aoki (S)

Japan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan.

Shoji F Nakayama (SF)

Japan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan.

Hiroshi Nitta (H)

Japan Environment and Children's Study Programme Office, National Institute for Environmental Studies, Tsukuba, Ibaraki, Japan.

Natsuha Ikeda (N)

Developmental Evaluation Center, National Center for Child Health and Development, Tokyo, Japan.

Keiko Kato (K)

Developmental Evaluation Center, National Center for Child Health and Development, Tokyo, Japan.

Satoshi Tamai (S)

Developmental Evaluation Center, National Center for Child Health and Development, Tokyo, Japan.

Makoto Takekoh (M)

Developmental Evaluation Center, National Center for Child Health and Development, Tokyo, Japan.

Masafumi Sanefuji (M)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kyushu University, Fukuoka, Japan.

Shouichi Ohga (S)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kyushu University, Fukuoka, Japan.

Masako Oda (M)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kumamoto University, Kumamoto, Japan.

Hiroshi Mitsubuchi (H)

Regional Center for Pilot Study of Japan Environment and Children's Study, Kumamoto University, Kumamoto, Japan.

Ayako Senju (A)

Regional Center for Pilot Study of Japan Environment and Children's Study, University of Occupational and Environmental Health, Kitakyushu, Japan.

Koichi Kusuhara (K)

Regional Center for Pilot Study of Japan Environment and Children's Study, University of Occupational and Environmental Health, Kitakyushu, Japan.

Mari Kuwajima (M)

Regional Center for Pilot Study of Japan Environment and Children's Study, Jichi Medical University, Shimotsuke, Japan.

Tatsuya Koeda (T)

Department of Psychosocial Medicine, National Center for Child Health and Development, Tokyo, Japan.

Yukihiro Ohya (Y)

Allergy Center, National Center for Child Health and Development, Tokyo, Japan.

Keiji Hashimoto (K)

Developmental Evaluation Center, National Center for Child Health and Development, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH